Welcome to our dedicated page for Trupanion SEC filings (Ticker: TRUP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Trupanion, Inc. (NASDAQ: TRUP) files a range of documents with the U.S. Securities and Exchange Commission that provide detailed insight into its business as a provider of medical insurance for cats and dogs. These SEC filings cover areas such as financial performance, risk factors, capital structure, governance, and material agreements that shape the company’s operations and its TRUP stock profile.
Key filings for Trupanion include annual reports on Form 10-K, which describe its subscription and other business segments, geographic reach, insurance entities, and risk considerations; and quarterly reports on Form 10-Q, which update investors on revenue from subscription and other business, enrolled pet counts, net income or loss, cash flows, and technology and development spending. Current reports on Form 8-K disclose material events, such as new credit agreements, earnings releases, and board appointments.
For example, Trupanion has used Form 8-K to report entering into a credit agreement with PNC Bank that provides term loan and revolving credit facilities secured by substantially all of the company’s and certain subsidiaries’ assets, and to announce the appointment of a new independent director to its board. Other 8-K filings reference the issuance of press releases detailing quarterly financial results.
Investors can also review Trupanion’s disclosures on non-GAAP financial measures, forward-looking statements, and risk factors, which are discussed in its periodic reports and referenced in earnings-related filings. These documents explain how the company views metrics such as adjusted EBITDA, net acquisition cost, and cash flow, and outline factors that could affect future performance, including claims trends, retention, regulatory constraints, and capital requirements.
On this page, Stock Titan presents Trupanion’s SEC filings alongside AI-powered summaries that highlight the main points of lengthy documents, such as 10-K and 10-Q reports. Users can quickly identify important information on segment performance, debt arrangements, and governance changes, while still having access to the full text of each filing for deeper review.
Darryl Rawlings, a director of Trupanion, Inc. (TRUP), reported two open-market sales of common stock. On 09/03/2025 he sold 19,631 shares at a weighted-average price of $44.7876, after which his indirect beneficial ownership through Kuyashii Primary Equities LLC was 1,443,650 shares. On 09/04/2025 he sold an additional 30,369 shares at a weighted-average price of $44.7002, leaving 1,413,281 indirectly beneficially owned. The Form 4 was signed by Christina Poler as attorney-in-fact on 09/05/2025. Footnotes state each reported price is a weighted average from multiple transactions and that the reporting person will provide transaction-level price breakdowns on request.
Form 144 filing for Trupanion, Inc. (TRUP) shows a proposed sale of 30,369 shares of common stock through Fidelity Brokerage Services with an aggregate market value of $135,794.30, and an approximate sale date of 09/04/2025 on NASDAQ. The filing lists the total shares outstanding as 42,994,675. Acquisition details show these shares were received primarily as stock awards from Trupanion on multiple dates between 2018 and 2025, and one small stock option exercise paid by cash/check. The filing also discloses a sale on 09/03/2025 by Rawlings Darryl of 19,631 shares generating $878,487.25 in gross proceeds. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Trupanion, Inc. (TRUP) Form 4 summary: Chief Financial Officer Fawwad Qureshi reported the exercise and sale of 6,451 shares of Trupanion common stock on 09/02/2025 under a Rule 10b5-1 trading plan adopted May 19, 2025, for financial diversification. The shares were sold in multiple transactions at prices ranging from $44.79 to $45.67, with a reported weighted-average price of $45.1548.
The filing shows 0 shares beneficially owned by the reporting person following the sale. The reporting person states the plan removed discretion over timing of transactions; further details on individual trade quantities by price are available upon request to the issuer or SEC staff.
Trupanion, Inc. (TRUP) Form 144 notice reports a proposed sale of 19,631 shares of common stock through Fidelity Brokerage Services with an aggregate market value of $878,487.25. The shares are listed on NASDAQ and the approximate date of sale is 09/03/2025 against 42,994,675 shares outstanding.
The filing details the acquisition history for the shares, showing numerous stock awards and one stock option from Trupanion between 2018 and 2025, with several large award grants recorded in November 2018. No securities were reported sold in the past three months. The filer certifies they are not aware of undisclosed material adverse information.
Trupanion, Inc. (TRUP) Form 144 notifies the proposed sale of 6,451 common shares through Morgan Stanley Smith Barney with an aggregate market value of $291,293.61. The filing lists total shares outstanding of 42,994,675 and an approximate sale date of 09/02/2025 on NASDAQ. The shares to be sold arise from restricted stock awards acquired on 05/22/2025 (3,545 shares) and 08/22/2025 (2,906 shares). The filer also disclosed a prior sale of 2,800 common shares on 08/26/2025 generating $127,573.88 in gross proceeds. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.
Darryl Rawlings, a director of Trupanion, Inc. (TRUP), reported multiple restricted stock unit (RSU) vesting events and transfers that changed his beneficial ownership. The Form 4 shows RSU conversions on 05/22/2025, 08/22/2025 and 08/25/2025 resulting in multiple small issuances of common stock and underlying RSU holdings tied to prior grants. The filing states a transfer of 634,172 shares to a limited liability company wholly owned by the reporting person and spouse, and reports indirect beneficial ownership of 1,463,281 shares via Kuyashii Primary Equities LLC. The form was signed by an attorney-in-fact on 08/27/2025.
Trupanion, Inc. (TRUP) insider Emily Dreyer reported automatic vesting and related tax-withholding of restricted stock units (RSUs). The filing shows RSUs vesting on 08/25/2025: 1,481 RSUs and 343 RSUs were recorded as acquired (vesting/converted into common stock). The issuer withheld 360 and 83 shares, respectively, to satisfy income tax withholding obligations, which the filer notes does not represent a sale. After these transactions the reporting person’s total direct beneficial ownership of common stock positions and RSU balances are updated in the Form 4 tables. The Form 4 was signed by an attorney-in-fact on behalf of Emily Dreyer.
Steve Weinrauch, Executive Vice President, North America & Vet Strategy at Trupanion, Inc. (TRUP), reported restricted stock unit vesting and related share withholding on 08/25/2025. Multiple tranches of RSUs converted into common stock: 353, 530 and 41 shares from different grants became vested and deliverable, and the issuer withheld shares to satisfy income tax withholding obligations rather than a sale by the reporting person. Form 4 shows disposition entries reflecting the withheld shares at a stated per-share amount of $45.83 for the withholding events. After the reported transactions, the filing lists the reporting person as beneficially owning 63,912 shares of common stock. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 08/27/2025.
Margaret Tooth, who is listed as both CEO and a Director of Trupanion, Inc. (TRUP), reported equity activity on Form 4 reflecting the vesting and conversion of restricted stock units into common stock on 08/25/2025. Two RSU groups converted into shares: 1,250 RSUs from a 2023 grant and 3,265 RSUs from a 2022 grant, adding stock to her direct holdings. The issuer withheld 491 and 1,284 shares, respectively, to satisfy tax withholding at a reported price of $45.83 per share; these withholdings are disclosures of remittance, not open-market sales. Beneficial ownership reported changed from 145,700 to 147,190 shares following the transactions. The form was signed by an attorney-in-fact on 08/27/2025.
Simon Wheeler, EVP, Trupanion International, reported multiple transactions in Trupanion, Inc. (TRUP) related to the vesting and conversion of restricted stock units (RSUs) on 08/25/2025. The filing shows 974 RSUs vested and converted into 974 shares of common stock and 322 RSUs vested and converted into 322 shares. The report also discloses that the issuer withheld 457 shares and 151 shares to satisfy income tax withholding obligations in connection with the RSU vesting; these withheld shares are not sales by the reporting person. After the transactions, the reporting person beneficially owned 19,341 shares, then 18,884 shares, then 19,206 shares, and finally 19,055 shares as shown on separate reported lines reflecting each event and withholding. The Form 4 was signed by an attorney-in-fact on 08/27/2025.
FAQ
What is the current stock price of Trupanion (TRUP)?
What is the market cap of Trupanion (TRUP)?
